Brown, Aisha Alayna
Widdowson, Michael
Brandt, Sarah
Mohammadzadeh, Parisa
Rosenberg, Julie B.
Jepsen, Jens Richardt Møllegaard
Ebdrup, Bjørn H.
Hernández-Lorca, María
Bønnelykke, Klaus
Chawes, Bo
Stokholm, Jakob
Thorsen, Jonathan
Ibrahimi, Parvaneh
Li, Xuanji
Sørensen, Søren Johannes
Rasmussen, Morten Arendt
Article History
Received: 2 December 2024
Accepted: 17 March 2025
First Online: 26 March 2025
Competing interests
: BHE is part of the Advisory Board of Boehringer Ingelheim, Lundbeck Pharma A/S; and has received lecture fees from Boehringer Ingelheim, Otsuka Pharma Scandinavia AB, and Lundbeck Pharma A/S. The authors declare no competing interests.